Manufacturers

MYoroface AB

Sjötullsgatan 16 , 82450 Hudiksvall
Sweden

Telephone +46 650 402237
info@myoroface.com

This company is co-exhibitor of
Business Sweden (The Swedish Trade & Invest Council)

Trade fair hall

  • Hall 1 / D18
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 1): stand D18

Fairground map

MEDICA 2016 fairground map: Hall 1

Contact

Terry Morris

Business Development Director

Phone
+46 (0)70 837 08 37
+44 (0)7518 511 620

Email
terry.morris@myoroface.com

Linn Hägg

Marketing and Sales Director

MYoroface AB c/o Sahlgrenska Science Park, Medicinaregatan 8A, V. 2
413 46 Gothenburg, Sweden

Phone
+46 (0)70 344 89 55

Email
linn@myoroface.com

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.10  Stimulation equipment for diagnostics / therapy

Stimulation equipment for diagnostics / therapy

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.10  Stimulation equipment for diagnostics / therapy
  • 01.03.10.05  Stimulators and accessories
  • 04  Physiotherapy / Orthopaedic Technology
  • 04.10  Physiotherapeutic massage equipment

Physiotherapeutic massage equipment

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.10  Physiotherapeutic massage equipment
  • 04.10.02  Neuromuscular stimulation therapy

Neuromuscular stimulation therapy

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.12  Rehabilitation equipment and devices

Rehabilitation equipment and devices

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.12  Rehabilitation equipment and devices
  • 04.12.19  Speech therapy equipment

Our products

Product category: Stimulation equipment for diagnostics / therapy, Stimulators and accessories, Physiotherapeutic massage equipment, Neuromuscular stimulation therapy, Rehabilitation equipment and devices, Speech therapy equipment

IQoro® - a neuromuscular exerciser and regime

MYoroface AB is a Swedish company with a new approach to orofacial problems with the product IQoro®.

The company is founded in science and research and has the highest levels of academic approval and validation. It works with and in renowned hospital and research institutions to advance its knowledge and solutions.

IQoro® is often used by surviving stroke patients with swallowing problems, and also to address the following:
  • Swallowing difficulties in any part of the chain from lips to stomach
  • Reflux and hiatus hernia
  • Speech difficulties caused by muscular impairment
  • Snoring
  • Apnoea

Patients with such problems may be stroke survivors, have been born with chromosomatic disorders, be elderly, have had physical injury or be cancer sufferers or survivors.

IQoro® is a neuromuscular exerciser and regime that works by exercising the swallowing muscles and stimulating the brain circuits that control them. Patients self-administer at home, reducing HCP intervention and costs and reducing patient attendance at healthcare institutions to a minimum. No drugs are involved.

The exercise routine is simple and non-invasive and involves just three minutes’ exercise per day. Results are typically seen within a couple of weeks and full correction is usually achieved inside three months in successful interventions. Studies show that 97% of interventions have a positive result.

MYoroface is successful in Sweden with sales both to State Health Authorities, and directly to private patients. Distribution outside of Sweden is minimal at present, and MYoroface will be at Medica to promote international expansion.

Please make contact if you are established or interested in this area.

More Less

About us

Company details

MYoroface develop and offers products for orofacial disorders. Eating, swallowing and breathing problems are treated by our product IQoro®.

In clinical scientific studies* IQoro® treats dysphagia after a brain-damage with up to 71% becoming normalized in swallowing capacity with a sustainable effect (97% have a significant improvement) and hiatus hernia whereof 100% are getting significant improved (between 53-74% symptom free depending on symptom). New independent studies planned on snoring/apnea patients, after a promising pre study.

We are offering an effective and easy treatment for clinical use as well as for the individual user, saving time and resources for the healthcare and the society. Independent calculations shows a minimum saving £ 4 100 per stroke patient with swallowing problems.

MYoroface is on the Swedish market with the product IQoro® since June 2014 and have county councils, individual hospitals and private care givers (ENT –departments, speech pathologists, dentists, rehabilitation centers, nursing centers) among the customers. As IQoro® is harmless and easy to use MYoroface also turns directly to private consumers.

More Less

Company data

Sales volume

< 1 Mio US $

Export content

max. 10%

Number of employees

1-19

Foundation

2012

Area of business

Electromedical equipment / Medical Technology